At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
We are very excited to launch our new website! Please take a few moments to click around and explore...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...